Amundi
BLFS icon

Amundi’s BioLife Solutions BLFS Stock Holding History

Amundi’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$276K Buy
+9,782
New +$229K ﹤0.01% 1875
2022
Q4 		– Sell
-3,785
Closed -$89K – 1907
2022
Q3 		$89K Hold
3,785
– – ﹤0.01% 1579
2022
Q2 		$59K Hold
3,785
– – ﹤0.01% 1525
2022
Q1 		$83K Hold
3,785
– – ﹤0.01% 1495
2021
Q4 		$116K Buy
+3,785
New +$162K ﹤0.01% 1551

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Amundi's BLFS Position: Q2 2026 in Review

Amundi opened a new position in BioLife Solutions (BLFS) in Q2 2026: 9,782 shares worth $276K. The stake represents ﹤0.01% of the portfolio and ranks #1875 among its holdings. This is a return to the name: Amundi previously reported a position in BLFS as recently as Q3 2022.

Amundi first reported a position in BLFS in Q4 2021 and has held it in 5 quarters since. 217 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Amundi held 9,782 shares of BioLife Solutions worth $276K as of Q2 2026.
  • BioLife Solutions was a new Amundi position in Q2 2026.
  • BioLife Solutions made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1875 holding.
  • Amundi first reported a position in BioLife Solutions in Q4 2021 and has held it in 5 quarters since.
  • 217 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.